Chronic non-atrophic gastritis C2

In general, chronic non-atrophic gastritis C2 refers to type C2 of chronic non-atrophic gastritis and may be associated with factors such as improper diet, decreased immunity, gastric mucosal injury, Helicobacter pylori infection, and bile reflux gastritis. Patients are advised to follow medical instructions for symptomatic treatment. The specific analysis is as follows:

1. Improper Diet

If a patient frequently overeats, consumes excessive spicy or irritating foods or beverages over a long period, the gastric mucosa may become damaged, leading to the development of chronic non-atrophic gastritis type C2. Patients should maintain regular eating habits, avoid spicy, stimulating, greasy, raw, or cold foods, and consume fresh fruits and vegetables appropriately, such as apples and tomatoes.

2. Medication Factors

Long-term use of non-steroidal anti-inflammatory drugs (NSAIDs), such as enteric-coated aspirin tablets or indomethacin enteric-coated tablets, may disrupt the mucus layer on the surface of the gastric mucosa or inhibit prostaglandin synthesis in gastric acid and gastric mucosa, resulting in mucosal damage and subsequently triggering chronic non-atrophic gastritis type C2. It is recommended that patients discontinue these medications promptly and switch to alternative treatments under a doctor's guidance.

3. Gastric Injury

Under normal circumstances, various injurious factors of sufficient intensity can cause gastric injury. Such injury may lead to congestion and edema of the gastric mucosa, thereby causing the aforementioned condition. Patients may take medications such as compound aluminum hydroxide tablets or rebamipide tablets under medical supervision.

4. Helicobacter pylori Infection

Helicobacter pylori infection is one of the causes of chronic non-atrophic gastritis type C2. After infection, the patient’s gastric mucosa undergoes prolonged and recurrent pathogen invasion and damage, leading to the above-mentioned condition. Patients may be treated under medical guidance with medications such as esomeprazole magnesium enteric-coated capsules or pantoprazole sodium enteric-coated capsules.

5. Bile Reflux Gastritis

Bile reflux gastritis may result in significant backflow of bile, pancreatic juice, and intestinal fluids into the stomach, irritating the gastric mucosa and thus causing chronic non-atrophic gastritis type C2. Patients may be treated under medical guidance with medications such as hydrotalcite chewable tablets or mosapride citrate tablets.

In addition, this condition may also be related to factors such as gastric ulcers or gastric cancer. If patients experience discomfort symptoms, they are advised to seek timely medical evaluation at a hospital to avoid delays in diagnosis and treatment.